Science, culture, complexity

Tag: Edzard Ernst

  • UCL cancels homeopathy event by Indian docs

    An India-based homeopathic organisation caused ripples in academic circles in the UK over the last few days after announcing it would conduct a conference on treating cancer at the University College London (UCL) premises – an appointment that has since been cancelled by UCL.

    Although homeopathy has been widely drubbed as possessing zero curative potential, it continues to have an existence ranging from undemonstrative to unrestrained in many countries. In the UK, its practice is restricted by law; further compounding the issue is that the scheduled conference plans to discuss ways to manage cancer with homeopathy, the kind of advertising that’s barely legal in the country (see: Section 4, Cancer Act, 1939).

    The website built for the event says that the Dr. Prasanta Banerji Homeopathic Research Foundation, based in Kolkata, will conduct the conference at the UCL Institute of Neurology, with an entry fee of £180. The two-day event will discuss the so-called Banerji Protocols, a set of methods developed by doctors Prasanta and Pratip Banerji to manage various ailments using only homeopathy and arrive at diagnoses quickly. However, their claims appear insufficiently backed up – a list of publications on the foundation’s page doesn’t contain any peer-reviewed studies or reports from randomised clinical trials.

    Once the event’s details were publicised, the furore was centred on the Banerjis’ using UCL premises to promote their methods. As Andy Lewis wrote in The Quackometer, “[UCL’s] premises are being used to bring respectability to a thoroughly disturbing business.” However, after complaints lodged by multiple activists, researchers and others, UCL cancelled the event on February 1 and said, according to blogger David Colquhoun, that the booking was made by a “junior [secretary] unaware of issues”, that it had learnt its lesson, and that a process had been set up to prevent similar issues from recurring in the future.

    The UCL clarification came close on the heels of the UK’s Medicines and Healthcare products Regulatory Authority approving five homeopathic combinations to make therapeutic claims. All combinations are made by a company named Helios and assure palliative and curative effects, including for hay fever. Edzard Ernst, noted for his vehement opposition to homeopathy, wrote in response on his blog, “If you look critically at the evidence, you are inevitably going to arrive at entirely different verdicts about the effectiveness of these remedies: they actually do nothing!”

    It’s notable that the marketing practices that the Banerjis are following closely mimic those generally adopted by people selling dubitable products, services or ideas:

    • Advertising methods through case studies instead of scientific details – Three items on the conference agenda read: “Evidence based management of cancer, renal failure and other serious illnesses with case presentations including radiology and histopathology images” and “Live case studies to demonstrate case taking for difficult conditions”
    • Conflating invitation from institutes with invitation from governments (the latter hardly ever happens) – From banerjiprotocols.in: “Under invitation from Spain, Portugal, Royal Academy of Japan, USA, Roswell park cancer centre at Buffalo, New York, Italy, Netherlands, Germany we have done workshops and teaching seminars and we received standing ovations in all the places.”
    • Citing alleged accreditation by prestigious institutions but of which no official record exists – Also from banerjiprotocols.in: “Our protocol for Brain cancer & Breast Cancer has been experimented by the scientist of the MD Anderson Cancer Centre, Houston, USA and found in vitro experiment that these medicines selectively kills cancer cells but not the normal cells. Joint paper by us and scientist, professor of cell biology and genetics has been published in International Journal of Oncology. Our work with National Cancer Institute, USA has been published in journal of Oncology Reports.” – The papers are not to be found.

    Others include referring to essays and books of their own authorship; presenting their publication as validation of their methods; not participating in any collaborative work, especially with accredited research institutions; and often labouring unto not insubstantial commercial gains.

    Despite a World Health Organisation directive in 2009 cautioning against the use of homeopathy to cure serious illnesses like malaria, it is officially counted among India’s national systems of medicine. Its research and practice receives support from the Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH) under the Ministry of Health and Family Welfare. From 1980 to 2010, the number of homeopathic doctors in the country doubled while the number of dispensaries increased four-fold.

    The Wire
    February 2, 2016

  • Curious Bends – homeopathy’s Nazi connections, painful science, the HepC bombshell and more

    1. Standing up for the truth about homeopathy and Nazi medicine

    “Few people would doubt the Nazi atrocities constituted the worst violations of ethics in the history of medicine. They were possible because doctors had disregarded the most elementary rules of medical ethics. Using unproven, disproven or unsafe treatments on misinformed patients, as in alternative medicine, is also hardly an ethical approach to healthcare. In fact, it violates Hippocrates’ essential principle of “first do no harm” in a most obvious way. These were some of the ideas I cover in my memoir, A Scientist in Wonderland. Just when the book had been written – and seemingly to prove my point – an extraordinary turn of events linked all these themes together in a most dramatic fashion.” (4 min read, irishtimes.com)

    2. How does the emerging world use technology?

    “Very few people in India and Bangladesh use the internet – only 20% and 11% respectively. But among those who do, job searching is a popular activity. Majorities of internet users in Bangladesh (62%) and India (55%) say they have looked for a job online in the past year, the highest rates among the 31 countries surveyed that have enough internet users to analyze.” (4 min read, pewresearch.org)

    3. For a renaissance in Indian science and technology

    “In addition, several premier research and development laboratories function without a regular director, examples being the Tata Institute of Fundamental Research in Mumbai, and the Indian Agricultural Research Institute in New Delhi. There is more. The last Union Budget speech had virtually no reference to science. Personally, I am aware of the erosion of excellence built painstakingly over the years in laboratories such as the Centre for Cellular & Molecular Biology in Hyderabad. Its library can no longer subscribe to even Current Contents leave alone other scientific journals as there is no money. I know that the ICMR cannot even pay appropriate travel allowance to those attending its meetings. I have not seen such situations arise in my scientific career spanning over six decades. The resource crunch that S&T labs face today is something unknown and is painful.” (7 min read, thehindu.com)

    + The author of this piece, Pushpa M. Bhargava, is the Chairman of the Council for Social Development (southern regional centre).

    4. An Indian won the 2015 Stockholm Water Prize for revitalising an ancient innovation

    “It look him a few months before finding his life’s mission—and it took an ancient innovation, a fast disappearing traditional technology, to help him transform the lives of thousands of villagers in one of India’s most arid regions. On March 20, Singh was awarded the 2015 Stockholm Water Prize, sometimes described as the Nobel prize for water. “Rajendra Singh did not insist with the clinics,” the Stockholm International Water Institute, which awards the prize, said in a statement. “Instead, and with the help of the villagers, he set out to build johads, or traditional earthen dams.”” (4 min read, qz.com)

    5. Now, silence is offered as a luxury good

    “Silence is now offered as a luxury good. In the business-class lounge at Charles de Gaulle Airport, I heard only the occasional tinkling of a spoon against china. I saw no advertisements on the walls. This silence, more than any other feature, is what makes it feel genuinely luxurious. When you step inside and the automatic doors whoosh shut behind you, the difference is nearly tactile, like slipping out of haircloth into satin. Your brow unfurrows, your neck muscles relax; after 20 minutes you no longer feel exhausted. Outside, in the peon section, is the usual airport cacophony. Because we have allowed our attention to be monetized, if you want yours back you’re going to have to pay for it.” (7 min read, nytimes.com)

    Chart of the Week

    “As the patent case winds its way through the legal labyrinth, there is both hope and disappointment. The hope springs from the belief that patent challenge to sofosbuvir is strong. The pre-grant opposition filed by I-MAK says the drug is not new and that the patent is based on old science that was disclosed in a 2005 application made by Gilead to India’s patent office. The disappointment stems from the fact that India’s top generic companies have caved in and opted for the safer option of VL agreements.” (10 min read, scroll.in)

    c8a5e989-36a6-48fb-80c9-f01dbb419a75